Solorank.ai
Login

Cached score snapshot

US.A · Agilent Technologies

110分制 51.6/110；5D動能v2 3/50；排序分 54.6/160

Back to ranking Open volume snapshot
Ranking score 54.6/160
Main score 51.6/110
5D momentum v2 3/50
Rank #283
Setup grade F 23.4

Score breakdown

避免

Medium twelvedata

Score and price trend

F 23.4 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 04-23 07-24 08-06 08-19 08-31 $104.76$130.81$156.85 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.819 · anchors 120 +1.10% -1.18% / +3.27% 61.6% 2.2% Actual +7.28% · vs median +6.18% · inside 25-75 band
30D observation +7.09% +1.85% / +12.99% 82% 7.2% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 +1.04% -0.57% / +3.40% 65.6% 1.3% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-04-23 → 2026-08-31 · 322 archived points · 3 Improving turn signal · 3 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 54.6
Display grade 避免
Model version cursor_18_27_news_v2_160
Main score 51.6/110 (避免)
5D momentum v2 3/50 (弱)
Score with momentum v2 54.6/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 132.3255
ma50 127.2524
close 130.26
prevClose 131.46
avgVolume20 2262464
volumeRatio 0.85
changePercent -0.91

Metrics snapshot

close 130.26
volume 1932079
changePercent -0.91

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 51.6/110
Main rating 避免
5D momentum v2 3/50
Score with momentum v2 54.6/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.6/5 · 良好
Dimension score 3.6/5
Dimension grade 良好

Sub-items

pbPoints 0.2
pePoints 0.2
epsPoints 0
roePoints 0.75
debtPoints 0.5
marginPoints 0.6
turnoverUsdM 251.6726
volumePoints 0.5
revenuePoints 0
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 6.8/20 · 較差
Dimension score 6.8/20
Dimension grade 較差

Sub-items

cmfPoints 0.8
mfiPoints 1.6
obvPoints 1.6
vwapPoints 0.8

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.A
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 7.2/15 · 較差
Dimension score 7.2/15
Dimension grade 較差

Sub-items

vix

score 1.8

details

source twelvedata+fred
vixClose 18.77

trend

score 0.8

details

qqq

ma20 716.1175
ma50 719.011
name QQQ
close 696.06
points 0.4

spy

ma20 744.7885
ma50 744.5456
name SPY
close 742.09
points 0.4
source twelvedata+fred
atrPct 2.7163
atrPoints 3
cciPoints 1.6
vixPoints 1.8
marketTrendPoints 0.8

催化劑 — 2/20 · 較差
Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 0
catalystPoints 2

風險管理 — 6.8/10 · 一般
Dimension score 6.8/10
Dimension grade 一般

Sub-items

position

score 1.6

details

atrPct 2.7163
turnoverUsdM 251.6726
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.A
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 123.1836

strength_details

ma_score 1.5
atr_score 2
rsi_score 1
macd_score 1.5
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 5.4
take_profit_price 136.773
target_multiplier 1.6
technical_strength 1.38
take_profit_percent 5
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.4325
diversificationPoints 2

技術信號 — 19.2/30 · 一般
Dimension score 19.2/30
Dimension grade 一般

Sub-items

bbPoints 2.4
adxPoints 3
sarPoints 2.4
vcpPoints 2.7
macdPoints 2.4

vcpPayload

vcp_pass false
vcp_score 2.7
vcp_reason 波幅收縮(13.4%→7.3%)；跌縮量(近10日3日)；站上MA50；升放量(近10日2日)；Ready=Y；Confirm=N

vcp_metrics

up_days 5
vol_ref 2289466.6667
down_days 4
vcp_ready true
above_ma50 true
avg_vol_10 2259890
avg_vol_20 2382575
avg_vol_30 2289466.6667
range_pct_10 0.0725
range_pct_20 0.1033
range_pct_30 0.1335
up_expand_ok true
lookback_used 59
near_20d_high true
contraction_ok true
down_shrink_ok true
up_expand_days 2
breakout_20d_ok false
vol_ratio_10_30 0.9871
dist_to_20d_high 0.0604
down_shrink_days 3
breakout_level_20d 138.63
vcp_breakout_confirm false
contraction_ratio_10_30 0.5434
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction true
kdjAdxPoints 0.5
rsiKdjPoints 2.4
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 0
shortMacdPoints 0.4
volConfirmPoints 0.6
volumePointsTechnical 0.8

情緒分析 — 6/10 · 一般
Dimension score 6/10
Dimension grade 一般

Sub-items

sentiment

score 6

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 0
positiveHits 4
sentimentScoreRaw 1.2

sentimentData

raw {"id":140907179,"url":"https://finnhub.io/api/news?id=340495186adc8c7a39222547fca20d68d8e33abc9353106904ef2fa4f9f6d435","image":"https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp","source":"ChartMill","related":"A","summary":"Agilent Technologies (A) shows a strong technical breakout setup with an 8/10 Technical Rating and 9/10 Setup Quality, combining a solid uptrend with a tight consolidation near a resistance zone for a potential energetic move.","category":"company","datetime":1784113828,"headline":"Agilent Technologies (NYSE:A) Shows Strong Breakout Setup with Top-Tier Technical Ratings"}, {"id":140891351,"url":"https://finnhub.io/api/news?id=e241c1ffe64c739ef93aa279e16d8b927df3ed6bdc10741dd02d51309b8e4eef","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"If you’re an Alamar Biosciences (ALMR) shareholder, Friday was a good day. The stock climbed +7.3%, closing the session at a new 52-week high of $28.42. That’s a tidy gain on a day when the S&P 500 barely nudged up +0.4% and some key industry peers actually lost ground.","category":"company","datetime":1783975817,"headline":"Alamar Hits A High Note On Alzheimer's Buzz"}, {"id":140891435,"url":"https://finnhub.io/api/news?id=b2c25386d7c3ec7bdeefe1aa97da53868cf1b24991f81ccde9342c2c6f03d2f3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Over the past six months, Agilent’s stock price fell to $134.31. Shareholders have lost 8.2% of their capital, which is disappointing considering the S&P 500 has climbed by 8.4%. This may have investors wondering how to approach the situation.","category":"company","datetime":1783975599,"headline":"Agilent (A): Buy, Sell, or Hold Post Q1 Earnings?"}, {"id":140851723,"url":"https://finnhub.io/api/news?id=adab0e54b2cd05edff59575e88d1eecd33a73d0980c3a0ffdfab4fcc4e7eb226","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1442797246/image_1442797246.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"Illumina dominates genomics sequencing with recurring growth, NovaSeq X catalysts, and improving margins/FCF. Click to know why the ILMN shares look promising.","category":"company","datetime":1783595255,"headline":"Illumina: While You Chased AI, This Healthcare Stock Built A $30B Moat"}, {"id":140841969,"url":"https://finnhub.io/api/news?id=929007abc6845945f0a033e193825ae16c6bff63e4c136fbb2550d41c7d31896","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. Agilent Technologies, Inc. (NYSE:A) is one of the best healthcare stocks on our list. TheFly reported on July 6 that Evercore ISI analyst Vijay Kumar increased the firm’s price target on A to $148 from $144 while maintaining an Outperform rating […]","category":"company","datetime":1783522222,"headline":"Is Agilent Technologies, Inc. (A) Stock Positioned for Growth as Life Sciences Sector Trends Stabilize?"}, {"id":140835525,"url":"https://finnhub.io/api/news?id=94b0899fa78390fbc58321c8109277f99f9fb5c37ef3cee2fd78ff7abbb2a8dd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies stock presents a clear valuation split right now, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while earnings-based market multiples imply the shares are already pricing in a lot of good news. Over the past 3 years, Agilent Technologies has returned 12.9%, which suggests the stock has rewarded patient holders but not in a way that obviously rules out further value questions. The recent launch of the AI powered xCELLigence RTCA...","category":"company","datetime":1783455830,"headline":"Agilent (A) Stock Looks Below Fair Value On Cash Flow"}, {"id":140738183,"url":"https://finnhub.io/api/news?id=66b65a87291865a86210f530a1b00adfaff915b2f4a95dc1db2427405312990b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1782487802,"headline":"Why Is Agilent (A) Up 0.1% Since Last Earnings Report?"}, {"id":140730497,"url":"https://finnhub.io/api/news?id=2aa7cdf7d5e75d552f598f1791581a5b2b53b2d36a27b8801fdb7ebd06341efe","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 3.9% in the morning session after it announced the completion of its acquisition of Biocare Medical, a deal the company expects to boost revenue growth and margins.","category":"company","datetime":1782426350,"headline":"Agilent (A) Stock Trades Up, Here Is Why"}
raw_source {"id":140957691,"url":"https://finnhub.io/api/news?id=3c6550e2c0800b60983455c135aeac81bcdf03b6df0b0290dada176b889299dd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"NOTTINGHAM, England, July 20, 2026--Multimillion dollar investment round to enable HALO to complete regulatory approval of its advanced security screening technology","category":"company","datetime":1784531460,"headline":"Agilent Increases Its Investment in HALO X-ray Technologies"}, {"id":140940379,"url":"https://finnhub.io/api/news?id=313b6b852fad87101bd818b159b0149e5266b64044b5717f092ff2ac4d12ad63","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read here for an analysis.","category":"company","datetime":1784329960,"headline":"Dividend Champion, Contender, And Challenger Highlights: Week Of July 19"}, {"id":140930814,"url":"https://finnhub.io/api/news?id=d3dc1c2d69ab4e39d8aae41aa150cf946d1a48da7f86ea954cc9ed3844b19c84","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Asia-Pacific will be the fastest-growing region. Key players include Roche, Thermo Fisher, Illumina, Agilent Technologies, and QIAGEN. Cancer Biomarkers Market Cancer Biomarkers Market Dublin, July 17, 2026 (GLOBE NEWSWIRE) -- The \"Cancer Biomarkers Market by Profiling Technology, Cancer, Product, Application, End User, And Region - Global Forecast to 2032\" has been added to ResearchAndMarkets.com's offering. Global market forecast indicates an 11.6% CAGR, with diagnostic laboratories holding th","category":"company","datetime":1784285040,"headline":"Cancer Biomarkers Market to Reach US$ 54.48 Billion by 2032 as Precision Oncology and Multi-Omics Adoption Accelerate"}, {"id":140908427,"url":"https://finnhub.io/api/news?id=87096e97df6ec0e551b5894ed17ca089758b3a68fe3ca283f186ea941b69d51d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.","category":"company","datetime":1784120477,"headline":"1 of Wall Street’s Favorite Stocks on Our Buy List and 2 We Brush Off"}, {"id":140907179,"url":"https://finnhub.io/api/news?id=340495186adc8c7a39222547fca20d68d8e33abc9353106904ef2fa4f9f6d435","image":"https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp","source":"ChartMill","related":"A","summary":"Agilent Technologies (A) shows a strong technical breakout setup with an 8/10 Technical Rating and 9/10 Setup Quality, combining a solid uptrend with a tight consolidation near a resistance zone for a potential energetic move.","category":"company","datetime":1784113828,"headline":"Agilent Technologies (NYSE:A) Shows Strong Breakout Setup with Top-Tier Technical Ratings"}, {"id":140897052,"url":"https://finnhub.io/api/news?id=d3c01461e553edff92f6fa26c92fb12931f2973b5417e40b825effd9af455f29","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"SANTA CLARA, Calif., July 14, 2026--Agilent Technologies Inc. (NYSE: A) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the PD‑L1 IHC 28‑8 pharmDx assay as a companion diagnostic to identify patients with esophageal squamous cell carcinoma (ESCC), gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma who may be eligible for treatment with OPDIVO® (nivolumab) or OPDIVO QVANTIG® (nivolumab and hyaluronidase‑nvhy), Bristol Myers Squibb’s P","category":"company","datetime":1784030400,"headline":"Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma"}, {"id":140897861,"url":"https://finnhub.io/api/news?id=7ed46f2519f301b40f26796faa434edf28b25ad1cb922969992a34846af05ea1","image":"","source":"Benzinga","related":"A","summary":"Approval for the PD‑L1 IHC 28‑8 pharmDx assay as a companion diagnostic to identify patients with esophageal squamous cell carcinoma (ESCC), gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma who","category":"company","datetime":1784016512,"headline":"Agilent Receives FDA Approval For The PD‑L1 LHC 28‑8 PharmDx Assay As Companion Diagnostic To Identify Patients With Carcinomas Who May Be Eligible For Treatment With OPDIVO or OPDIVO QVANTIG"}, {"id":140891351,"url":"https://finnhub.io/api/news?id=e241c1ffe64c739ef93aa279e16d8b927df3ed6bdc10741dd02d51309b8e4eef","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"If you’re an Alamar Biosciences (ALMR) shareholder, Friday was a good day. The stock climbed +7.3%, closing the session at a new 52-week high of $28.42. That’s a tidy gain on a day when the S&P 500 barely nudged up +0.4% and some key industry peers actually lost ground.","category":"company","datetime":1783975817,"headline":"Alamar Hits A High Note On Alzheimer's Buzz"}, {"id":140891435,"url":"https://finnhub.io/api/news?id=b2c25386d7c3ec7bdeefe1aa97da53868cf1b24991f81ccde9342c2c6f03d2f3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Over the past six months, Agilent’s stock price fell to $134.31. Shareholders have lost 8.2% of their capital, which is disappointing considering the S&P 500 has climbed by 8.4%. This may have investors wondering how to approach the situation.","category":"company","datetime":1783975599,"headline":"Agilent (A): Buy, Sell, or Hold Post Q1 Earnings?"}, {"id":140854874,"url":"https://finnhub.io/api/news?id=bff9ea6966cfd21f8e8d8baf218327bc3ed365657dbabb38f53b68db40ee60fc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"A enhances AI-powered lab software, automation and digital workflows to support drug discovery, biopharma research and long-term growth.","category":"company","datetime":1783619580,"headline":"Agilent Strengthens Biopharma Growth Prospects With AI Expansion"}, {"id":140851723,"url":"https://finnhub.io/api/news?id=adab0e54b2cd05edff59575e88d1eecd33a73d0980c3a0ffdfab4fcc4e7eb226","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1442797246/image_1442797246.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"Illumina dominates genomics sequencing with recurring growth, NovaSeq X catalysts, and improving margins/FCF. Click to know why the ILMN shares look promising.","category":"company","datetime":1783595255,"headline":"Illumina: While You Chased AI, This Healthcare Stock Built A $30B Moat"}, {"id":140841969,"url":"https://finnhub.io/api/news?id=929007abc6845945f0a033e193825ae16c6bff63e4c136fbb2550d41c7d31896","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. Agilent Technologies, Inc. (NYSE:A) is one of the best healthcare stocks on our list. TheFly reported on July 6 that Evercore ISI analyst Vijay Kumar increased the firm’s price target on A to $148 from $144 while maintaining an Outperform rating […]","category":"company","datetime":1783522222,"headline":"Is Agilent Technologies, Inc. (A) Stock Positioned for Growth as Life Sciences Sector Trends Stabilize?"}, {"id":140840661,"url":"https://finnhub.io/api/news?id=7474ad0e0ddf65f60b4ee001e92025316c8059b306b8c1ebe631753c931f1535","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"SANTA CLARA, Calif., July 08, 2026--Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to support critical analytical workflows in biopharmaceutical development and production.","category":"company","datetime":1783512000,"headline":"Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis"}, {"id":140835525,"url":"https://finnhub.io/api/news?id=94b0899fa78390fbc58321c8109277f99f9fb5c37ef3cee2fd78ff7abbb2a8dd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies stock presents a clear valuation split right now, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while earnings-based market multiples imply the shares are already pricing in a lot of good news. Over the past 3 years, Agilent Technologies has returned 12.9%, which suggests the stock has rewarded patient holders but not in a way that obviously rules out further value questions. The recent launch of the AI powered xCELLigence RTCA...","category":"company","datetime":1783455830,"headline":"Agilent (A) Stock Looks Below Fair Value On Cash Flow"}, {"id":140822551,"url":"https://finnhub.io/api/news?id=cee2ec535267e843a0b8f16ab25239634407c46036ba5069e90df7d6cd04facb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Surplus Solutions LLC (\"Surplus Solutions\"), a portfolio company of NMS Capital (\"NMS\"), announced today the acquisition of DCM BioServices (\"DCM Bio\" or the \"Company\"), a Frederick, Maryland-based provider of laboratory automation maintenance, repair, technical support, and integration solutions. The acquisition expands Surplus Solutions' technical service capabilities and supports the Company's continued growth in the biotechnology, pharmaceutical, and life sciences sectors. Terms of the trans","category":"company","datetime":1783358040,"headline":"Surplus Solutions, an NMS Capital Portfolio Company, Accelerates Technical Service Capabilities; Announces Partnership with DCM BioServices"}, {"id":140821772,"url":"https://finnhub.io/api/news?id=b03b0addb0d7acdbf47fda5c877fd3fee0fe08fe9b79b1b286111a4b4df934d5","image":"","source":"Benzinga","related":"A","summary":"Evercore ISI Group analyst Vijay Kumar maintains Agilent Technologies (NYSE:A) with a Outperform and raises the price target from $144 to $148.","category":"company","datetime":1783336119,"headline":"Evercore ISI Group Maintains Outperform on Agilent Technologies, Raises Price Target to $148"}, {"id":140818525,"url":"https://finnhub.io/api/news?id=e8e67091f2f83771cb62d3ba1db83ca7b564b4ea75343756e5eddb52ce7632de","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"The global mobile mass spectrometers market is set to grow from USD 1.68 billion in 2026 to USD 2.87 billion by 2031, at a CAGR of 11.3%. This significant growth is driven by the demand for real-time, on-site chemical analysis in diverse industries such as environmental monitoring and defense. Ion sources top market components, with their pivotal role in sampling and analysis. Field-deployable platforms lead the product segment, offering portability essential for immediate results. North America","category":"company","datetime":1783327440,"headline":"Mobile Mass Spectrometers Market by Application, Product Type & Component Global Forecast to 2031"}, {"id":140779657,"url":"https://finnhub.io/api/news?id=27678fa4b44f44e51d5561053a6524bbf641d1fe08cd61da09d690c89e908395","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"SANTA CLARA, Calif., July 01, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual cell segmentation steps and parameter tuning and supporting more consistent results. The software upgrade enhances the unique dual-readout capabilities of the Agilent xCELLigence RTCA eSight instrument with AI-driven cell imaging analysis, enabling researchers to ga","category":"company","datetime":1782907200,"headline":"Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight"}, {"id":140772145,"url":"https://finnhub.io/api/news?id=848c46f2007d6cb833f16d6b8bce3b184f6f2cfe022d47a8a2c58ad0b0ba0d34","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Experienced finance executive joins AdCellerant to support continued growth, operational scale, and long-term financial strategyDENVER, June 30, 2026 (GLOBE NEWSWIRE) -- AdCellerant, a leading digital advertising technology and services company, announced today the appointment of Jonathan Kalstein as Chief Financial Officer, where he will help guide the company’s financial strategy as it expands its platform, partner network, and omnichannel advertising capabilities. Kalstein has held CFO and se","category":"company","datetime":1782824400,"headline":"AdCellerant Appoints Jonathan Kalstein as Chief Financial Officer"}, {"id":140740729,"url":"https://finnhub.io/api/news?id=e2ecfe7423e0385e993151624a54a5d758f2b095b51c5e3aa85f275016df6d8d","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read it here.","category":"company","datetime":1782496544,"headline":"Dividend Champion, Contender, And Challenger Highlights: Week Of June 28"}, {"id":140738183,"url":"https://finnhub.io/api/news?id=66b65a87291865a86210f530a1b00adfaff915b2f4a95dc1db2427405312990b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1782487802,"headline":"Why Is Agilent (A) Up 0.1% Since Last Earnings Report?"}, {"id":140736655,"url":"https://finnhub.io/api/news?id=cf31b7bad58ef09d4aeaa0fd01cd0e336195c11b1e3d76df3faeeb9ee5359867","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"The acquisition strengthens Agilent’s presence in areas including cancer and infectious disease diagnostic and research markets.","category":"company","datetime":1782468000,"headline":"Agilent finalizes Biocare Medical takeover"}, {"id":140736938,"url":"https://finnhub.io/api/news?id=705f74c6283473d51455eef5e6f512f623e9f6c39295fc7a0f25df78b27b4083","image":"","source":"Benzinga","related":"A","summary":"Bernstein analyst Eve Burstein reinstates Agilent Technologies (NYSE:A) with a Outperform and announces $155 price target.","category":"company","datetime":1782464369,"headline":"Bernstein Reinstates Outperform on Agilent Technologies, Announces $155 Price Target"}, {"id":140730497,"url":"https://finnhub.io/api/news?id=2aa7cdf7d5e75d552f598f1791581a5b2b53b2d36a27b8801fdb7ebd06341efe","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 3.9% in the morning session after it announced the completion of its acquisition of Biocare Medical, a deal the company expects to boost revenue growth and margins.","category":"company","datetime":1782426350,"headline":"Agilent (A) Stock Trades Up, Here Is Why"}, {"id":140724811,"url":"https://finnhub.io/api/news?id=0e4cc50bc9c905e51c1ebc6c5744a1851e863bbd5b1fe193a9a6f7a16c231290","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Agilent Technologies, Inc. (NYSE:A) is among the best healthcare stocks. TheFly reported on June 11 that Piper Sandler began coverage of A with a Neutral rating and established a $150.00 price target. The firm initiated coverage of the […]","category":"company","datetime":1782391326,"headline":"Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler"}, {"id":140724812,"url":"https://finnhub.io/api/news?id=3466c5935286f321089f71325848a2db1a0436e56974a775d2665939ef8deec5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Denver, CO and London, UK – 25 June 2026: Excellere Partners (“Excellere”), a Denver-based private equity firm specializing in partnering with entrepreneurs and management teams, and GHO Capital Partners LLP (“GHO”), a specialist investor in global healthcare, today announced the completion of the sale of Biocare Medical (\"Biocare\"), a global leader in immunohistochemistry (IHC), in situ hybridization (ISH) and fluorescence in situ hybridization (FISH) solutions, to Agilent Technologies, Inc. (\"","category":"company","datetime":1782389160,"headline":"Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies"}, {"id":140724813,"url":"https://finnhub.io/api/news?id=8bcad38bea13080efc11b2f7f296246dcd49219a39c4571b8b0e97be6f2de234","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"SANTA CLARA, Calif., June 25, 2026--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group.","category":"company","datetime":1782388800,"headline":"Agilent Completes Acquisition of Biocare Medical"}, {"id":140724303,"url":"https://finnhub.io/api/news?id=b57611ff77fa1e0abbc44541bd9e9b8b6b4070cbf01bc0a0d2468b6b47f059ae","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1405583561/image_1405583561.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"Equity markets are at historically high valuations, with the Shiller CAPE near dot-com bubble territory and broad market indices showing stretched multiples.","category":"company","datetime":1782378900,"headline":"2 Preferred Shares Paying 7%+ When The Market Panics"}, {"id":140717096,"url":"https://finnhub.io/api/news?id=94b7d0bff663500e008b569194f7c24b2393b2c6331878775fce6236aef3dfc1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Laboratory Equipment Services Market size & share revenue was valued at approximately USD 28.94 Billion in 2025 and is expected to reach USD 31.47 Billion in 2026 and is expected to reach around USD 62.83 Billion by 2035, at a CAGR of 8% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Thermo Fisher Scien","category":"company","datetime":1782329400,"headline":"Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)"}, {"id":140712670,"url":"https://finnhub.io/api/news?id=ef0fee1e42e64e8a18bc4c69f26b54f40fad3706a9dfdf777f5060462e4f9234","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1148805607/image_1148805607.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"Read this month's roundup of news for lithium miners here.","category":"company","datetime":1782293790,"headline":"Lithium Miners News For The Month Of June 2026"}, {"id":140692762,"url":"https://finnhub.io/api/news?id=917ce303d946f6be6809d73ad357e9a862053a1e7f6654f325fd874162d000ba","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Investors need to pay close attention to A stock based on the movements in the options market lately.","category":"company","datetime":1782135600,"headline":"Is the Options Market Predicting a Spike in Agilent Technologies Stock?"}, {"id":140684374,"url":"https://finnhub.io/api/news?id=423fd7f539c0dd144d7773d5fabf13d92fd8526c319a7deb25d21eccf8225936","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies (A) has been in focus after reporting quarterly results that exceeded analyst expectations on both revenue and earnings. The company raised full-year guidance and paired that update with expansion moves in China and cancer diagnostics. See our latest analysis for Agilent Technologies. Agilent Technologies' latest earnings beat and guidance raise have arrived alongside a 10.53% 1 month share price return and a 13.43% 3 month share price return. The stock's year to date...","category":"company","datetime":1782036497,"headline":"Agilent Technologies (A) Stock Could Be 23% Undervalued After Earnings Beat And Guidance Raise"}, {"id":140683597,"url":"https://finnhub.io/api/news?id=cb943124bc351246470ad2080faee04c8f4124540a363079401b8ffba4701ec2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies recently reported stronger-than-expected Q1 and Q2 results, raised full-year revenue and EPS guidance, and outlined plans to open a China Innovation Center while acquiring Biocare to broaden its cancer diagnostics capabilities. These developments highlight how Agilent is pairing operational improvements with targeted innovation in AI-driven automation and diagnostics to broaden its laboratory solutions footprint. Next, we will examine how Agilent’s upgraded full-year...","category":"company","datetime":1782021981,"headline":"How Investors May Respond To Agilent Technologies (A) Upgraded Outlook And Push Into AI-Powered Diagnostics"}, {"id":140678738,"url":"https://finnhub.io/api/news?id=1da03ce5ff74bd525c52726b7931ab348915e1c9d7b199f1e543940d87fa876b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies (NYSE:A) plans to open a new China Innovation Center focused on digital, AI, and automation research and development. The company also announced the acquisition of Biocare to expand its presence in cancer diagnostics. These initiatives mark an expansion into areas tied to advanced technology and healthcare testing. Agilent Technologies enters this phase of expansion with its stock trading at $127.06 and a value score of 5. The share price is up 10.7% over the past 30...","category":"company","datetime":1781968032,"headline":"Agilent (A) Opens China Innovation Center And Buys Biocare For Cancer Diagnostics"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 0
positive_hits 4
recomputed_at_score true
sentiment_score_raw 1.2
source_article_count 34
discarded_article_count 20
sentimentPoints 6

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.6 5/110 72% 3.6
資金流 6.8 20/110 34% 6.8
市場環境 7.2 15/110 48% 7.2
催化劑 2 20/110 10% 2
風險管理 6.8 10/110 68% 6.8
技術信號 19.2 30/110 64% 19.2
情緒分析 6 10/110 60% 6

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 3/50
ret_5d -0.0282
max_score 50
max_total 50
raw_total 3
vcp_bonus 0
vol_ratio 0.8109
ret_points 0
vol_points 0
range_ratio 0.7818
volat_points 0
day_range_pct 0.0205
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 3
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 2.7163
turnoverUsdM 251.6726
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.A
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 123.1836

strength_details

ma_score 1.5
atr_score 2
rsi_score 1
macd_score 1.5
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 5.4
take_profit_price 136.773
target_multiplier 1.6
technical_strength 1.38
take_profit_percent 5
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.4325
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.6/5分
資金流分析總分: 6.8/20分
市場環境分析總分: 7.2/15分
催化劑分析: 2/20分
風險管理總分: 6.8/10分
技術信號分析總分: 19.2/30分
情緒分析: 6/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 92.86
atr
atr 3.5382
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.72
cci
rule Cursor_18.24 CCI bands
level 弱勢
score 4
value -38.39
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.0754
kdj
d 62.24
j 37.12
k 53.87
rule Cursor_18.24 K/D cross
score 0
signal 死叉
mfi
rule Cursor_18.24 MFI bands
level 弱流入
score 4
value 48.02
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 4
trend 弱勢
value 28477921
recentSlope -410707.9
previousSlope 873280
rsi
value 43.67
sar
rule Cursor_18.24 Parabolic SAR
score 8
trend 上升
value 124.1974
position SAR喺價下
distancePct 4.65
previousTrend 上升
ma50
value 127.2524
macd
macd 1.3781
trend 中性偏多
signal 1.8256
histogram -0.4474
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 2
value 132.3743
position <VWAP
consecutiveAbove 0
volume
rule Cursor_18.24 volume ratio
level 無力
ratio 0.85
score 4
avgVolume 2262464
currentVolume 1932079
derived
ma20 132.3255
ma50 127.2524
prevClose 131.46
avgVolume10 2253108
avgVolume20 2262464
changePercent -0.91
avgVolumeForScore 2262464
ma_cross
ma20 132.3255
ma50 127.2524
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 132.1655
prevMa50 127.001
spreadPct 3.99
isVolumeBreakout false
bollinger
lower 126.8274
upper 137.8236
position 中間
rsi_short
value 27.93
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 0.85

Raw calculation JSON

 
{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.7162599966421,
        "turnoverUsdM": 251.67259121920998,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.A",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 123.1836,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 1,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 5.4,
      "take_profit_price": 136.773,
      "target_multiplier": 1.6,
      "technical_strength": 1.38,
      "take_profit_percent": 5
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.4325199932842,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 54.6,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 51.6,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 3
  },
  "market": {
    "ma20": 132.3255,
    "ma50": 127.2524,
    "close": 130.26,
    "prevClose": 131.46,
    "avgVolume20": 2262464,
    "volumeRatio": 0.85,
    "changePercent": -0.91
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 3,
    "details": {
      "ret_5d": -0.028200561007191483,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 3,
      "vcp_bonus": 0,
      "vol_ratio": 0.8109205376535891,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.7818259120419111,
      "volat_points": 0,
      "day_range_pct": 0.020535852950702756,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 54.6,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.6,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 72,
        "contribution": 3.6
      },
      {
        "raw": 6.8,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 34,
        "contribution": 6.8
      },
      {
        "raw": 7.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 48,
        "contribution": 7.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.8,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 68,
        "contribution": 6.8
      },
      {
        "raw": 19.2,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 64,
        "contribution": 19.2
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 51.6,
    "details": [
      "基本面分析總分: 3.6/5分",
      "資金流分析總分: 6.8/20分",
      "市場環境分析總分: 7.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.8/10分",
      "技術信號分析總分: 19.2/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.6,
      "資金流": 6.8,
      "市場環境": 7.2,
      "情緒分析": 6,
      "技術信號": 19.2,
      "風險管理": 6.8
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.75,
          "debtPoints": 0.5,
          "marginPoints": 0.6,
          "turnoverUsdM": 251.67259121920998,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 1.6,
          "obvPoints": 1.6,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.A",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 18.77
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 716.11750425,
                "ma50": 719.0110022000002,
                "name": "QQQ",
                "close": 696.059998,
                "points": 0.4
              },
              "spy": {
                "ma20": 744.7885068500001,
                "ma50": 744.54560184,
                "name": "SPY",
                "close": 742.090027,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.7162599966421,
          "atrPoints": 3,
          "cciPoints": 1.6,
          "vixPoints": 1.8,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 4,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140907179,
                "url": "https://finnhub.io/api/news?id=340495186adc8c7a39222547fca20d68d8e33abc9353106904ef2fa4f9f6d435",
                "image": "https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp",
                "source": "ChartMill",
                "related": "A",
                "summary": "Agilent Technologies (A) shows a strong technical breakout setup with an 8/10 Technical Rating and 9/10 Setup Quality, combining a solid uptrend with a tight consolidation near a resistance zone for a potential energetic move.",
                "category": "company",
                "datetime": 1784113828,
                "headline": "Agilent Technologies (NYSE:A) Shows Strong Breakout Setup with Top-Tier Technical Ratings"
              },
              {
                "id": 140891351,
                "url": "https://finnhub.io/api/news?id=e241c1ffe64c739ef93aa279e16d8b927df3ed6bdc10741dd02d51309b8e4eef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "If you’re an Alamar Biosciences (ALMR) shareholder, Friday was a good day. The stock climbed +7.3%, closing the session at a new 52-week high of $28.42. That’s a tidy gain on a day when the S&P 500 barely nudged up +0.4% and some key industry peers actually lost ground.",
                "category": "company",
                "datetime": 1783975817,
                "headline": "Alamar Hits A High Note On Alzheimer's Buzz"
              },
              {
                "id": 140891435,
                "url": "https://finnhub.io/api/news?id=b2c25386d7c3ec7bdeefe1aa97da53868cf1b24991f81ccde9342c2c6f03d2f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Over the past six months, Agilent’s stock price fell to $134.31. Shareholders have lost 8.2% of their capital, which is disappointing considering the S&P 500 has climbed by 8.4%. This may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1783975599,
                "headline": "Agilent (A): Buy, Sell, or Hold Post Q1 Earnings?"
              },
              {
                "id": 140851723,
                "url": "https://finnhub.io/api/news?id=adab0e54b2cd05edff59575e88d1eecd33a73d0980c3a0ffdfab4fcc4e7eb226",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1442797246/image_1442797246.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "Illumina dominates genomics sequencing with recurring growth, NovaSeq X catalysts, and improving margins/FCF. Click to know why the ILMN shares look promising.",
                "category": "company",
                "datetime": 1783595255,
                "headline": "Illumina: While You Chased AI, This Healthcare Stock Built A $30B Moat"
              },
              {
                "id": 140841969,
                "url": "https://finnhub.io/api/news?id=929007abc6845945f0a033e193825ae16c6bff63e4c136fbb2550d41c7d31896",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. Agilent Technologies, Inc. (NYSE:A) is one of the best healthcare stocks on our list. TheFly reported on July 6 that Evercore ISI analyst Vijay Kumar increased the firm’s price target on A to $148 from $144 while maintaining an Outperform rating […]",
                "category": "company",
                "datetime": 1783522222,
                "headline": "Is Agilent Technologies, Inc. (A) Stock Positioned for Growth as Life Sciences Sector Trends Stabilize?"
              },
              {
                "id": 140835525,
                "url": "https://finnhub.io/api/news?id=94b0899fa78390fbc58321c8109277f99f9fb5c37ef3cee2fd78ff7abbb2a8dd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies stock presents a clear valuation split right now, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while earnings-based market multiples imply the shares are already pricing in a lot of good news. Over the past 3 years, Agilent Technologies has returned 12.9%, which suggests the stock has rewarded patient holders but not in a way that obviously rules out further value questions. The recent launch of the AI powered xCELLigence RTCA...",
                "category": "company",
                "datetime": 1783455830,
                "headline": "Agilent (A) Stock Looks Below Fair Value On Cash Flow"
              },
              {
                "id": 140738183,
                "url": "https://finnhub.io/api/news?id=66b65a87291865a86210f530a1b00adfaff915b2f4a95dc1db2427405312990b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1782487802,
                "headline": "Why Is Agilent (A) Up 0.1% Since Last Earnings Report?"
              },
              {
                "id": 140730497,
                "url": "https://finnhub.io/api/news?id=2aa7cdf7d5e75d552f598f1791581a5b2b53b2d36a27b8801fdb7ebd06341efe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 3.9% in the morning session after it announced the completion of its acquisition of Biocare Medical, a deal the company expects to boost revenue growth and margins.",
                "category": "company",
                "datetime": 1782426350,
                "headline": "Agilent (A) Stock Trades Up, Here Is Why"
              }
            ],
            "raw_source": [
              {
                "id": 140957691,
                "url": "https://finnhub.io/api/news?id=3c6550e2c0800b60983455c135aeac81bcdf03b6df0b0290dada176b889299dd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "NOTTINGHAM, England, July 20, 2026--Multimillion dollar investment round to enable HALO to complete regulatory approval of its advanced security screening technology",
                "category": "company",
                "datetime": 1784531460,
                "headline": "Agilent Increases Its Investment in HALO X-ray Technologies"
              },
              {
                "id": 140940379,
                "url": "https://finnhub.io/api/news?id=313b6b852fad87101bd818b159b0149e5266b64044b5717f092ff2ac4d12ad63",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read here for an analysis.",
                "category": "company",
                "datetime": 1784329960,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of July 19"
              },
              {
                "id": 140930814,
                "url": "https://finnhub.io/api/news?id=d3dc1c2d69ab4e39d8aae41aa150cf946d1a48da7f86ea954cc9ed3844b19c84",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Asia-Pacific will be the fastest-growing region. Key players include Roche, Thermo Fisher, Illumina, Agilent Technologies, and QIAGEN. Cancer Biomarkers Market Cancer Biomarkers Market Dublin, July 17, 2026 (GLOBE NEWSWIRE) -- The \"Cancer Biomarkers Market by Profiling Technology, Cancer, Product, Application, End User, And Region - Global Forecast to 2032\" has been added to ResearchAndMarkets.com's offering. Global market forecast indicates an 11.6% CAGR, with diagnostic laboratories holding th",
                "category": "company",
                "datetime": 1784285040,
                "headline": "Cancer Biomarkers Market to Reach US$ 54.48 Billion by 2032 as Precision Oncology and Multi-Omics Adoption Accelerate"
              },
              {
                "id": 140908427,
                "url": "https://finnhub.io/api/news?id=87096e97df6ec0e551b5894ed17ca089758b3a68fe3ca283f186ea941b69d51d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.",
                "category": "company",
                "datetime": 1784120477,
                "headline": "1 of Wall Street’s Favorite Stocks on Our Buy List and 2 We Brush Off"
              },
              {
                "id": 140907179,
                "url": "https://finnhub.io/api/news?id=340495186adc8c7a39222547fca20d68d8e33abc9353106904ef2fa4f9f6d435",
                "image": "https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp",
                "source": "ChartMill",
                "related": "A",
                "summary": "Agilent Technologies (A) shows a strong technical breakout setup with an 8/10 Technical Rating and 9/10 Setup Quality, combining a solid uptrend with a tight consolidation near a resistance zone for a potential energetic move.",
                "category": "company",
                "datetime": 1784113828,
                "headline": "Agilent Technologies (NYSE:A) Shows Strong Breakout Setup with Top-Tier Technical Ratings"
              },
              {
                "id": 140897052,
                "url": "https://finnhub.io/api/news?id=d3c01461e553edff92f6fa26c92fb12931f2973b5417e40b825effd9af455f29",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "SANTA CLARA, Calif., July 14, 2026--Agilent Technologies Inc. (NYSE: A) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the PD‑L1 IHC 28‑8 pharmDx assay as a companion diagnostic to identify patients with esophageal squamous cell carcinoma (ESCC), gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma who may be eligible for treatment with OPDIVO® (nivolumab) or OPDIVO QVANTIG® (nivolumab and hyaluronidase‑nvhy), Bristol Myers Squibb’s P",
                "category": "company",
                "datetime": 1784030400,
                "headline": "Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma"
              },
              {
                "id": 140897861,
                "url": "https://finnhub.io/api/news?id=7ed46f2519f301b40f26796faa434edf28b25ad1cb922969992a34846af05ea1",
                "image": "",
                "source": "Benzinga",
                "related": "A",
                "summary": "Approval for the PD‑L1 IHC 28‑8 pharmDx assay as a companion diagnostic to identify patients with esophageal squamous cell carcinoma (ESCC), gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma who",
                "category": "company",
                "datetime": 1784016512,
                "headline": "Agilent Receives FDA Approval For The PD‑L1 LHC 28‑8 PharmDx Assay As Companion Diagnostic To Identify Patients With Carcinomas Who May Be Eligible For Treatment With OPDIVO or OPDIVO QVANTIG"
              },
              {
                "id": 140891351,
                "url": "https://finnhub.io/api/news?id=e241c1ffe64c739ef93aa279e16d8b927df3ed6bdc10741dd02d51309b8e4eef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "If you’re an Alamar Biosciences (ALMR) shareholder, Friday was a good day. The stock climbed +7.3%, closing the session at a new 52-week high of $28.42. That’s a tidy gain on a day when the S&P 500 barely nudged up +0.4% and some key industry peers actually lost ground.",
                "category": "company",
                "datetime": 1783975817,
                "headline": "Alamar Hits A High Note On Alzheimer's Buzz"
              },
              {
                "id": 140891435,
                "url": "https://finnhub.io/api/news?id=b2c25386d7c3ec7bdeefe1aa97da53868cf1b24991f81ccde9342c2c6f03d2f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Over the past six months, Agilent’s stock price fell to $134.31. Shareholders have lost 8.2% of their capital, which is disappointing considering the S&P 500 has climbed by 8.4%. This may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1783975599,
                "headline": "Agilent (A): Buy, Sell, or Hold Post Q1 Earnings?"
              },
              {
                "id": 140854874,
                "url": "https://finnhub.io/api/news?id=bff9ea6966cfd21f8e8d8baf218327bc3ed365657dbabb38f53b68db40ee60fc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "A enhances AI-powered lab software, automation and digital workflows to support drug discovery, biopharma research and long-term growth.",
                "category": "company",
                "datetime": 1783619580,
                "headline": "Agilent Strengthens Biopharma Growth Prospects With AI Expansion"
              },
              {
                "id": 140851723,
                "url": "https://finnhub.io/api/news?id=adab0e54b2cd05edff59575e88d1eecd33a73d0980c3a0ffdfab4fcc4e7eb226",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1442797246/image_1442797246.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "Illumina dominates genomics sequencing with recurring growth, NovaSeq X catalysts, and improving margins/FCF. Click to know why the ILMN shares look promising.",
                "category": "company",
                "datetime": 1783595255,
                "headline": "Illumina: While You Chased AI, This Healthcare Stock Built A $30B Moat"
              },
              {
                "id": 140841969,
                "url": "https://finnhub.io/api/news?id=929007abc6845945f0a033e193825ae16c6bff63e4c136fbb2550d41c7d31896",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. Agilent Technologies, Inc. (NYSE:A) is one of the best healthcare stocks on our list. TheFly reported on July 6 that Evercore ISI analyst Vijay Kumar increased the firm’s price target on A to $148 from $144 while maintaining an Outperform rating […]",
                "category": "company",
                "datetime": 1783522222,
                "headline": "Is Agilent Technologies, Inc. (A) Stock Positioned for Growth as Life Sciences Sector Trends Stabilize?"
              },
              {
                "id": 140840661,
                "url": "https://finnhub.io/api/news?id=7474ad0e0ddf65f60b4ee001e92025316c8059b306b8c1ebe631753c931f1535",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "SANTA CLARA, Calif., July 08, 2026--Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to support critical analytical workflows in biopharmaceutical development and production.",
                "category": "company",
                "datetime": 1783512000,
                "headline": "Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis"
              },
              {
                "id": 140835525,
                "url": "https://finnhub.io/api/news?id=94b0899fa78390fbc58321c8109277f99f9fb5c37ef3cee2fd78ff7abbb2a8dd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies stock presents a clear valuation split right now, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while earnings-based market multiples imply the shares are already pricing in a lot of good news. Over the past 3 years, Agilent Technologies has returned 12.9%, which suggests the stock has rewarded patient holders but not in a way that obviously rules out further value questions. The recent launch of the AI powered xCELLigence RTCA...",
                "category": "company",
                "datetime": 1783455830,
                "headline": "Agilent (A) Stock Looks Below Fair Value On Cash Flow"
              },
              {
                "id": 140822551,
                "url": "https://finnhub.io/api/news?id=cee2ec535267e843a0b8f16ab25239634407c46036ba5069e90df7d6cd04facb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Surplus Solutions LLC (\"Surplus Solutions\"), a portfolio company of NMS Capital (\"NMS\"), announced today the acquisition of DCM BioServices (\"DCM Bio\" or the \"Company\"), a Frederick, Maryland-based provider of laboratory automation maintenance, repair, technical support, and integration solutions. The acquisition expands Surplus Solutions' technical service capabilities and supports the Company's continued growth in the biotechnology, pharmaceutical, and life sciences sectors. Terms of the trans",
                "category": "company",
                "datetime": 1783358040,
                "headline": "Surplus Solutions, an NMS Capital Portfolio Company, Accelerates Technical Service Capabilities; Announces Partnership with DCM BioServices"
              },
              {
                "id": 140821772,
                "url": "https://finnhub.io/api/news?id=b03b0addb0d7acdbf47fda5c877fd3fee0fe08fe9b79b1b286111a4b4df934d5",
                "image": "",
                "source": "Benzinga",
                "related": "A",
                "summary": "Evercore ISI Group  analyst Vijay Kumar   maintains Agilent Technologies (NYSE:A) with a Outperform and raises the price target from $144 to $148.",
                "category": "company",
                "datetime": 1783336119,
                "headline": "Evercore ISI Group Maintains Outperform on Agilent Technologies, Raises Price Target to $148"
              },
              {
                "id": 140818525,
                "url": "https://finnhub.io/api/news?id=e8e67091f2f83771cb62d3ba1db83ca7b564b4ea75343756e5eddb52ce7632de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "The global mobile mass spectrometers market is set to grow from USD 1.68 billion in 2026 to USD 2.87 billion by 2031, at a CAGR of 11.3%. This significant growth is driven by the demand for real-time, on-site chemical analysis in diverse industries such as environmental monitoring and defense. Ion sources top market components, with their pivotal role in sampling and analysis. Field-deployable platforms lead the product segment, offering portability essential for immediate results. North America",
                "category": "company",
                "datetime": 1783327440,
                "headline": "Mobile Mass Spectrometers Market by Application, Product Type & Component Global Forecast to 2031"
              },
              {
                "id": 140779657,
                "url": "https://finnhub.io/api/news?id=27678fa4b44f44e51d5561053a6524bbf641d1fe08cd61da09d690c89e908395",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "SANTA CLARA, Calif., July 01, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual cell segmentation steps and parameter tuning and supporting more consistent results. The software upgrade enhances the unique dual-readout capabilities of the Agilent xCELLigence RTCA eSight instrument with AI-driven cell imaging analysis, enabling researchers to ga",
                "category": "company",
                "datetime": 1782907200,
                "headline": "Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight"
              },
              {
                "id": 140772145,
                "url": "https://finnhub.io/api/news?id=848c46f2007d6cb833f16d6b8bce3b184f6f2cfe022d47a8a2c58ad0b0ba0d34",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Experienced finance executive joins AdCellerant to support continued growth, operational scale, and long-term financial strategyDENVER, June 30, 2026 (GLOBE NEWSWIRE) -- AdCellerant, a leading digital advertising technology and services company, announced today the appointment of Jonathan Kalstein as Chief Financial Officer, where he will help guide the company’s financial strategy as it expands its platform, partner network, and omnichannel advertising capabilities. Kalstein has held CFO and se",
                "category": "company",
                "datetime": 1782824400,
                "headline": "AdCellerant Appoints Jonathan Kalstein as Chief Financial Officer"
              },
              {
                "id": 140740729,
                "url": "https://finnhub.io/api/news?id=e2ecfe7423e0385e993151624a54a5d758f2b095b51c5e3aa85f275016df6d8d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read it here.",
                "category": "company",
                "datetime": 1782496544,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of June 28"
              },
              {
                "id": 140738183,
                "url": "https://finnhub.io/api/news?id=66b65a87291865a86210f530a1b00adfaff915b2f4a95dc1db2427405312990b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1782487802,
                "headline": "Why Is Agilent (A) Up 0.1% Since Last Earnings Report?"
              },
              {
                "id": 140736655,
                "url": "https://finnhub.io/api/news?id=cf31b7bad58ef09d4aeaa0fd01cd0e336195c11b1e3d76df3faeeb9ee5359867",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "The acquisition strengthens Agilent’s presence in areas including cancer and infectious disease diagnostic and research markets.",
                "category": "company",
                "datetime": 1782468000,
                "headline": "Agilent finalizes Biocare Medical takeover"
              },
              {
                "id": 140736938,
                "url": "https://finnhub.io/api/news?id=705f74c6283473d51455eef5e6f512f623e9f6c39295fc7a0f25df78b27b4083",
                "image": "",
                "source": "Benzinga",
                "related": "A",
                "summary": "Bernstein  analyst Eve Burstein   reinstates Agilent Technologies (NYSE:A) with a Outperform and announces $155 price target.",
                "category": "company",
                "datetime": 1782464369,
                "headline": "Bernstein Reinstates Outperform on Agilent Technologies, Announces $155 Price Target"
              },
              {
                "id": 140730497,
                "url": "https://finnhub.io/api/news?id=2aa7cdf7d5e75d552f598f1791581a5b2b53b2d36a27b8801fdb7ebd06341efe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 3.9% in the morning session after it announced the completion of its acquisition of Biocare Medical, a deal the company expects to boost revenue growth and margins.",
                "category": "company",
                "datetime": 1782426350,
                "headline": "Agilent (A) Stock Trades Up, Here Is Why"
              },
              {
                "id": 140724811,
                "url": "https://finnhub.io/api/news?id=0e4cc50bc9c905e51c1ebc6c5744a1851e863bbd5b1fe193a9a6f7a16c231290",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Agilent Technologies, Inc. (NYSE:A) is among the best healthcare stocks. TheFly reported on June 11 that Piper Sandler began coverage of A with a Neutral rating and established a $150.00 price target. The firm initiated coverage of the […]",
                "category": "company",
                "datetime": 1782391326,
                "headline": "Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler"
              },
              {
                "id": 140724812,
                "url": "https://finnhub.io/api/news?id=3466c5935286f321089f71325848a2db1a0436e56974a775d2665939ef8deec5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Denver, CO and London, UK – 25 June 2026: Excellere Partners (“Excellere”), a Denver-based private equity firm specializing in partnering with entrepreneurs and management teams, and GHO Capital Partners LLP (“GHO”), a specialist investor in global healthcare, today announced the completion of the sale of Biocare Medical (\"Biocare\"), a global leader in immunohistochemistry (IHC), in situ hybridization (ISH) and fluorescence in situ hybridization (FISH) solutions, to Agilent Technologies, Inc. (\"",
                "category": "company",
                "datetime": 1782389160,
                "headline": "Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies"
              },
              {
                "id": 140724813,
                "url": "https://finnhub.io/api/news?id=8bcad38bea13080efc11b2f7f296246dcd49219a39c4571b8b0e97be6f2de234",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "SANTA CLARA, Calif., June 25, 2026--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group.",
                "category": "company",
                "datetime": 1782388800,
                "headline": "Agilent Completes Acquisition of Biocare Medical"
              },
              {
                "id": 140724303,
                "url": "https://finnhub.io/api/news?id=b57611ff77fa1e0abbc44541bd9e9b8b6b4070cbf01bc0a0d2468b6b47f059ae",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1405583561/image_1405583561.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "Equity markets are at historically high valuations, with the Shiller CAPE near dot-com bubble territory and broad market indices showing stretched multiples.",
                "category": "company",
                "datetime": 1782378900,
                "headline": "2 Preferred Shares Paying 7%+ When The Market Panics"
              },
              {
                "id": 140717096,
                "url": "https://finnhub.io/api/news?id=94b7d0bff663500e008b569194f7c24b2393b2c6331878775fce6236aef3dfc1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Laboratory Equipment Services Market size & share revenue was valued at approximately USD 28.94 Billion in 2025 and is expected to reach USD 31.47 Billion in 2026 and is expected to reach around USD 62.83 Billion by 2035, at a CAGR of 8% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Thermo Fisher Scien",
                "category": "company",
                "datetime": 1782329400,
                "headline": "Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)"
              },
              {
                "id": 140712670,
                "url": "https://finnhub.io/api/news?id=ef0fee1e42e64e8a18bc4c69f26b54f40fad3706a9dfdf777f5060462e4f9234",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1148805607/image_1148805607.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "Read this month's roundup of news for lithium miners here.",
                "category": "company",
                "datetime": 1782293790,
                "headline": "Lithium Miners News For The Month Of June 2026"
              },
              {
                "id": 140692762,
                "url": "https://finnhub.io/api/news?id=917ce303d946f6be6809d73ad357e9a862053a1e7f6654f325fd874162d000ba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Investors need to pay close attention to A stock based on the movements in the options market lately.",
                "category": "company",
                "datetime": 1782135600,
                "headline": "Is the Options Market Predicting a Spike in Agilent Technologies Stock?"
              },
              {
                "id": 140684374,
                "url": "https://finnhub.io/api/news?id=423fd7f539c0dd144d7773d5fabf13d92fd8526c319a7deb25d21eccf8225936",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies (A) has been in focus after reporting quarterly results that exceeded analyst expectations on both revenue and earnings. The company raised full-year guidance and paired that update with expansion moves in China and cancer diagnostics. See our latest analysis for Agilent Technologies. Agilent Technologies' latest earnings beat and guidance raise have arrived alongside a 10.53% 1 month share price return and a 13.43% 3 month share price return. The stock's year to date...",
                "category": "company",
                "datetime": 1782036497,
                "headline": "Agilent Technologies (A) Stock Could Be 23% Undervalued After Earnings Beat And Guidance Raise"
              },
              {
                "id": 140683597,
                "url": "https://finnhub.io/api/news?id=cb943124bc351246470ad2080faee04c8f4124540a363079401b8ffba4701ec2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies recently reported stronger-than-expected Q1 and Q2 results, raised full-year revenue and EPS guidance, and outlined plans to open a China Innovation Center while acquiring Biocare to broaden its cancer diagnostics capabilities. These developments highlight how Agilent is pairing operational improvements with targeted innovation in AI-driven automation and diagnostics to broaden its laboratory solutions footprint. Next, we will examine how Agilent’s upgraded full-year...",
                "category": "company",
                "datetime": 1782021981,
                "headline": "How Investors May Respond To Agilent Technologies (A) Upgraded Outlook And Push Into AI-Powered Diagnostics"
              },
              {
                "id": 140678738,
                "url": "https://finnhub.io/api/news?id=1da03ce5ff74bd525c52726b7931ab348915e1c9d7b199f1e543940d87fa876b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies (NYSE:A) plans to open a new China Innovation Center focused on digital, AI, and automation research and development. The company also announced the acquisition of Biocare to expand its presence in cancer diagnostics. These initiatives mark an expansion into areas tied to advanced technology and healthcare testing. Agilent Technologies enters this phase of expansion with its stock trading at $127.06 and a value score of 5. The share price is up 10.7% over the past 30...",
                "category": "company",
                "datetime": 1781968032,
                "headline": "Agilent (A) Opens China Innovation Center And Buys Biocare For Cancer Diagnostics"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 4,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 34,
            "discarded_article_count": 20
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 19.2,
        "grade": "一般",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 2.7,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.7,
            "vcp_reason": "波幅收縮(13.4%→7.3%)；跌縮量(近10日3日)；站上MA50；升放量(近10日2日)；Ready=Y；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 2289466.6666666665,
              "down_days": 4,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 2259890,
              "avg_vol_20": 2382575,
              "avg_vol_30": 2289466.6666666665,
              "range_pct_10": 0.07254721883519263,
              "range_pct_20": 0.10333180587531134,
              "range_pct_30": 0.13350220585768519,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9870814163415061,
              "dist_to_20d_high": 0.06037661400851192,
              "down_shrink_days": 3,
              "breakout_level_20d": 138.63,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.5434158811767408
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.7162599966421,
              "turnoverUsdM": 251.67259121920998,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.A",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 123.1836,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 1,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 5.4,
            "take_profit_price": 136.773,
            "target_multiplier": 1.6,
            "technical_strength": 1.38,
            "take_profit_percent": 5
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.4325199932842,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 3.5382,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.72
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "弱勢",
      "score": 4,
      "value": -38.39
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0754
    },
    "kdj": {
      "d": 62.24,
      "j": 37.12,
      "k": 53.87,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 48.02
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 4,
      "trend": "弱勢",
      "value": 28477921,
      "recentSlope": -410707.9,
      "previousSlope": 873280
    },
    "rsi": 43.67,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 124.1974,
      "position": "SAR喺價下",
      "distancePct": 4.65,
      "previousTrend": "上升"
    },
    "ma50": 127.2524,
    "macd": {
      "macd": 1.3781358343086367,
      "trend": "中性偏多",
      "signal": 1.8255798095021847,
      "histogram": -0.44744397519354795
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 132.3743,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.85,
      "score": 4,
      "avgVolume": 2262464,
      "currentVolume": 1932079
    },
    "derived": {
      "ma20": 132.3255,
      "ma50": 127.2524,
      "prevClose": 131.46,
      "avgVolume10": 2253108,
      "avgVolume20": 2262464,
      "changePercent": -0.91,
      "avgVolumeForScore": 2262464
    },
    "ma_cross": {
      "ma20": 132.3255,
      "ma50": 127.2524,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 132.1655,
      "prevMa50": 127.001,
      "spreadPct": 3.99,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 126.8274,
      "upper": 137.8236,
      "position": "中間"
    },
    "rsi_short": 27.93,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.85
    }
  }
}

Raw metrics JSON

 
{
  "close": 130.26,
  "volume": 1932079,
  "changePercent": -0.91
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.